Registration Dossier

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
17 September 2012 to 24 October 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report Date:
2012

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Deviations:
no
Qualifier:
according to
Guideline:
EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
Deviations:
no
GLP compliance:
yes (incl. certificate)

Test material

Reference
Name:
Unnamed
Type:
Constituent
Test material form:
semi-solid (amorphous): gel

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Strain: Hsdlf:NZW
- Age at study initiation: 12 to 20 weeks
- Weight at study initiation: 2.25 or 2.95 kg
- Housing: The animals were individually housed in suspended cages.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): Free access to mains drinking water.
- Acclimation period: At least 5 days.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23 °C
- Humidity (%): 30 to 70 %
- Air changes (per hr): At least 15 per hour.
- Photoperiod (hrs dark / hrs light): The lighting was controlled by a time switch to give twelve hours continuous light (0600 to 1800) and twelve hours darkness.

IN-LIFE DATES: From: 17 September 2012 To: 24 October 2012

Test system

Vehicle:
unchanged (no vehicle)
Controls:
other: The left eye remained untreated and was used for control purposes.
Amount / concentration applied:
0.1 mL
Duration of treatment / exposure:
The upper and lower eyelids were held together for about one second immediately after treatment, to prevent loss of the test material, and then released.
Observation period (in vivo):
21 days
Number of animals or in vitro replicates:
2
Details on study design:
SCORING SYSTEM: Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment, according to the Draize numerical evaluation.
Additional observations were made on Days 7, 14 and 21 to assess the reversibility of the ocular effects. Individual bodyweights were recorded on Day 0 (the day of dosing) and at the end of the observation period. Any clinical signs of toxicity, if present, were also recorded.

Draize Scale for Scoring Ocular Irritation

1. CONJUNCTIVAE

Redness (refers to palpebral and bulbar conjunctivae excluding cornea and iris)
Vessels normal............................................................................................................................................0
Vessels definitely injected above normal................................................................................................1
More diffuse, deeper crimson red, individual vessels not easily discernible....................................2
Diffuse beefy red.........................................................................................................................................3

Chemosis
No swelling..................................................................................................................................................0
Any swelling above normal (includes nictitating membrane).............................................................1
Obvious swelling with partial eversion of lids.......................................................................................2
Swelling with lids about half closed.........................................................................................................3
Swelling with lids half closed to completely closed...............................................................................4

Discharge
No discharge...............................................................................................................................................0
Any amount different from normal (does not include small amounts observed in inner
canthus of normal animals)......................................................................................................................1
Discharge with moistening of the lids and hairs just adjacent to lids...............................................2
Discharge with moistening of the lids and hairs a considerable area around the eye...................3

2. IRIS

Values
Normal.........................................................................................................................................................0
Folds above normal, congestion, swelling, circumcorneal injection (any or all
of these or combination of any thereof) iris still reacting to light
(sluggish reaction is positive).................................................................................................................1
No reaction to light, haemorrhage, gross destruction (any or all of these)....................................2

3. CORNEA

Degree of Opacity (most dense area used)
No opacity...................................................................................................................................................0
Scattered or diffuse areas, details of iris clearly visible......................................................................1
Easily discernible translucent areas, details of iris slightly obscured..............................................2
Opalescent areas, no details of iris visible, size of pupil barely discernible....................................3
Opaque, iris not discernible through the opacity................................................................................4

Area of Cornea Involved
One quarter (or less) but not zero..........................................................................................................1
Greater than one quarter but less than half...........................................................................................2
Greater than half but less than three quarters......................................................................................3
Greater than three quarters, up to whole area.......................................................................................4

TOOL USED TO ASSESS SCORE: Any additional ocular effects were also noted. Examination of the eye was facilitated by the use of the light source from a standard ophthalmoscope.

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
cornea opacity score
Basis:
mean
Remarks:
of 2 animals
Time point:
24/48/72 h
Score:
1
Max. score:
1
Reversibility:
fully reversible within: 14 days
Irritation parameter:
iris score
Basis:
mean
Remarks:
of 2 animals
Time point:
24/48/72 h
Score:
0.83
Max. score:
1
Reversibility:
fully reversible within: 14 days
Irritation parameter:
conjunctivae score
Remarks:
(redness)
Basis:
mean
Remarks:
of 2 animals
Time point:
24/48/72 h
Score:
2
Max. score:
2
Reversibility:
fully reversible within: 21 days
Irritation parameter:
chemosis score
Basis:
mean
Remarks:
of 2 animals
Time point:
24/48/72 h
Score:
2
Max. score:
2
Reversibility:
fully reversible within: 21 days
Irritation parameter:
other: discharge score
Basis:
mean
Remarks:
of 2 animals
Time point:
24/48/72 h
Score:
1.67
Max. score:
3
Reversibility:
fully reversible within: 14 days
Irritant / corrosive response data:
Individual scores for ocular irritation are given in Table 1.
Scattered or diffuse corneal opacity was noted in both treated eyes one hour after treatment and at the 24, 48, 72 hour and 7 day observations.
Iridial inflammation was noted in all treated eyes one hour after treatment and at the 24 and 48 hour observations. Iridial inflammation was noted in one treated eye at the 72 hour observation and in both treated eyes at the 7 day observation.
Moderate conjunctival irritation was noted in both treated eyes one hour after treatment and at the 24, 48, 72 hour observations. Moderate conjunctival irritation was noted in one treated eye and minimal conjunctival irritation was noted in the other treated eye at the 7 day observation. Minimal conjunctival irritation was noted in one treated eye at the 14 day observation.

One treated eye appeared normal at the 14 day observation and the other treated eye appeared normal at the 21 day observation.
Other effects:
BODYWEIGHT
Both animals showed the expected gain in bodyweight during the study.

Any other information on results incl. tables

Table 1 Individual Scores for Ocular Irritation

Rabbit Number and Sex

72425 Male

72537 Male

IPR = 2

IPR = 2

Time After Treatment

1

hour

24 hours

48 hours

72 hours

7

days

14 days

1

hour

24 hours

48 hours

72 hours

7

days

14 days

21 days

Cornea

Degree

Area

 

1

1

 

1

1

 

1

2

 

1

2

 

1

1

 

0

0

 

1

2

 

1

2

 

1

2

 

1

2

 

1

2

 

0

0

 

0

0

Iris

1

1

1

0

1

0

1

1

1

1

1

0

0

Redness

2

2

2

2

1

0

2

2

2

2

2

2

0

Chemosis

2

2

2

2

1

0

2

2

2

2

2

1

0

Discharge

2

2

1

1

0

0

3

3

2

1

1

0

0

IPR = Initial pain reaction; a score of 2 indicates slight initial pain. The rabbit blinks and tries to open the eye but reflex closes it.

Applicant's summary and conclusion

Interpretation of results:
other: Category 2 (irritating to eyes) based on CLP criteria
Conclusions:
Eye irritant
Executive summary:

The irritancy potential of the test material was assessed in vivo in accordance with the standardised guidelines OECD 405 and EU Method B.5 under GLP conditions.

A single application of the test material was sequentially administered to the right eye of two New Zealand White rabbits. The treated eyes were not irrigated; the left eye remained untreated and served as the control. The animals were observed for 21 days.

Administration of the test material produced scattered or diffuse corneal opacity, iridial inflammation and moderate conjunctival irritation. One treated eye appeared normal at the 14 day observation; the other treated eye appeared normal at the 21 day observation.

Under the conditions of this study, the test material causes irritation to the eye and requires classification as Category 2 in accordance with EU criteria.